BMS 907351,
BMS-907351,
BMS907351,
cabozantinib,
Cometriq,
XL 184,
XL-184,
XL184 cpd,
1140909-48-3,
Cabozantinib S-malate,
cabozantinib (S)-malate,
Cabozantinib malate,
Cabozantinib malate (XL184),
Cabometyx,
Cabozantinib (S-malate),
Cabozantinib L-Malate Salt,
UNII-DR7ST46X58,
Cometriq,
Cabozantinib s-malate [USAN],
DR7ST46X58,
BMS907351,
CHEBI:72319,
Cometriq (TN),
Cabozantinib s-malate (USAN),
(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1),
cabozantinib-malate,
cabozantinib L-malate,
Cabozantinib malate (JAN),
XL184(Cabozantinib malate),
MLS006010951,
CHEMBL2103868,
HFCFMRYTXDINDK-WNQIDUERSA-N,
C28H24FN3O5.C4H6O5,
KS-00000LA2,
2296AH,
MFCD20923480,
s4001,
AKOS025401945,
CS-0201,
SB17293,
AC-27471,
HY-12044,
SC-91041,
SMR004702755,
SW218093-2,
D10095,
W-5841,
(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(,
(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluor,
(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide,
(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1),
1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate),
Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1),
cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt,
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate,
N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate,
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (2S)-2-Hydroxybutanedioic Acid,
N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate,
XL184,
XL 184,
XL-184,
BMS 907351,
1140909-48-3 (malate salt),
B1401,
Cabozantinib malate, 98%, a potent VEGFR2 inhibitor - 10MG 10mg,
849217-68-1,